Table 2.
The effects of treatments on the serum concentrations of FT3, FT4, and thyroid-stimulating hormone
| Groups | FT3 (pmol/L) | FT4 (pmol/L) | TSH mIU/L |
|---|---|---|---|
| Control | 3.19±0.53 | 28.38±5.29 | 1.29±0.26 |
| PCOS | 3.27±0.79 | 21.29±5.87# | 2.92±0.38# |
| PCOS +Zn Met 25 | 3.32±0.89 | 22.40±4.48 | 2.82±0.40 |
| PCOS +Zn Met 75 | 3.80±0.82 | 35.99±3.17˟ | 1.96±0.29˟ |
| PCOS +Zn Met 175 | 4.27±0.79 | 39.76±3.55˟ | 1.60±0.27˟ |
| P | 0.180 | 0.0001 | 0.0001 |
Data are expressed as mean±SD. #P<0.05; differences between Control group and PCOS group, ˟P<0.05; differences between PCOS group and PCOS treated groups. TSH: Thyroid-stimulating hormone, PCOS: Polycystic ovarian syndrome, SD: Standard deviation